BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu JY, Cheng CC, Wang JY, Wu DC, Hsieh JS, Lee SC, Wang WM. Discovery of tumor markers for gastric cancer by proteomics. PLoS One 2014;9:e84158. [PMID: 24404153 DOI: 10.1371/journal.pone.0084158] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 González-Sánchez JA, Vitón R, Collantes E, Rodríguez-Montes JA. Primary Squamous Cell Carcinoma of the Stomach. Clin Med Insights Oncol 2017;11:1179554916686076. [PMID: 28469507 DOI: 10.1177/1179554916686076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
2 Farid SG, Morris-Stiff G. "OMICS" technologies and their role in foregut primary malignancies. Curr Probl Surg. 2015;52:409-441. [PMID: 26527526 DOI: 10.1067/j.cpsurg.2015.08.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
3 Coghlin C, Murray GI. Progress in the development of protein biomarkers of oesophageal and gastric cancers. Prot Clin Appl 2016;10:532-45. [DOI: 10.1002/prca.201500079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
4 Robotti E, Marengo E. 2D-DIGE and Fluorescence Image Analysis. Methods Mol Biol 2018;1664:25-39. [PMID: 29019122 DOI: 10.1007/978-1-4939-7268-5_3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
5 Leja M, You W, Camargo MC, Saito H. Implementation of gastric cancer screening - the global experience. Best Pract Res Clin Gastroenterol. 2014;28:1093-1106. [PMID: 25439074 DOI: 10.1016/j.bpg.2014.09.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
6 Tanase C, Albulescu R, Neagu M. Proteomic Approaches for Biomarker Panels in Cancer. J Immunoassay Immunochem 2016;37:1-15. [PMID: 26565430 DOI: 10.1080/15321819.2015.1116009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Repetto O, De Re V, Giuffrida P, Lenti MV, Magris R, Venerito M, Steffan A, Di Sabatino A, Cannizzaro R. Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer. Gastric Cancer 2021;24:666-79. [PMID: 33620602 DOI: 10.1007/s10120-020-01148-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Repetto O, De Re V. Coagulation and fibrinolysis in gastric cancer. Ann N Y Acad Sci. 2017;1404:27-48. [PMID: 28833193 DOI: 10.1111/nyas.13454] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
9 Cheng CW, Chang CC, Patria YN, Chang RT, Liu YR, Li FA, Shih HM, Lin CY. Sex hormone-binding globulin (SHBG) is a potential early diagnostic biomarker for gastric cancer. Cancer Med 2018;7:64-74. [PMID: 29148252 DOI: 10.1002/cam4.1254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
10 Janciauskiene S, Wrenger S, Günzel S, Gründing AR, Golpon H, Welte T. Potential Roles of Acute Phase Proteins in Cancer: Why Do Cancer Cells Produce or Take Up Exogenous Acute Phase Protein Alpha1-Antitrypsin? Front Oncol 2021;11:622076. [PMID: 33680966 DOI: 10.3389/fonc.2021.622076] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Kang C, Lee Y, Lee JE. Recent advances in mass spectrometry-based proteomics of gastric cancer. World J Gastroenterol 2016; 22(37): 8283-8293 [PMID: 27729735 DOI: 10.3748/wjg.v22.i37.8283] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
12 Ljujic M, Mijatovic S, Bulatovic MZ, Mojic M, Maksimovic-ivanic D, Radojkovic D, Topic A. Alpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines. Pathol Oncol Res 2017;23:335-43. [DOI: 10.1007/s12253-016-0104-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Mohri Y, Toiyama Y, Kusunoki M. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics. Expert Rev Proteomics. 2016;13:1131-1139. [PMID: 27744719 DOI: 10.1080/14789450.2016.1249469] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
14 Damale MG, Patil RB, Ansari SA, Alkahtani HM, Almehizia AA, Shinde DB, Arote R, Sangshetti J. Molecular docking, pharmacophore based virtual screening and molecular dynamics studies towards the identification of potential leads for the management of H. pylori. RSC Adv 2019;9:26176-208. [DOI: 10.1039/c9ra03281a] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wang Y, Wang JH, Zhang XL, Wang XL, Yang L. Endoplasmic reticulum chaperone glucose-regulated protein 78 in gastric cancer: An emerging biomarker. Oncol Lett 2018;15:6087-93. [PMID: 29616092 DOI: 10.3892/ol.2018.8114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
16 Zhang S, Khaliq J, Li D, Jiang X, Sun R, Li Y. Robotic total gastrectomy with π-shaped esophagojejunostomy using a linear stapler as a novel technique. World J Surg Oncol 2018;16:238. [PMID: 30577805 DOI: 10.1186/s12957-018-1542-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Pérez-Holanda S, Blanco I, Menéndez M, Rodrigo L. Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls. BMC Cancer 2014;14:355. [PMID: 24886427 DOI: 10.1186/1471-2407-14-355] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
18 Aizat WM, Hassan M. Proteomics in Systems Biology. In: Aizat WM, Goh H, Baharum SN, editors. Omics Applications for Systems Biology. Cham: Springer International Publishing; 2018. pp. 31-49. [DOI: 10.1007/978-3-319-98758-3_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Yang W, Raufi A, Klempner SJ. Targeted therapy for gastric cancer: molecular pathways and ongoing investigations. Biochim Biophys Acta. 2014;1846:232-237. [PMID: 24858418 DOI: 10.1016/j.bbcan.2014.05.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 47] [Article Influence: 2.4] [Reference Citation Analysis]
20 Aziz F, Xin M, Gao Y, Chakroborty A, Khan I, Monts J, Monson K, Bode AM, Dong Z. Induction and Prevention of Gastric Cancer with Combined Helicobacter Pylori and Capsaicin Administration and DFMO Treatment, Respectively. Cancers (Basel) 2020;12:E816. [PMID: 32231118 DOI: 10.3390/cancers12040816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kim SY, Park C, Kim HJ, Park J, Hwang J, Kim JI, Choi MG, Kim S, Kim KM, Kang MS. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes. Gastroenterology. 2015;148:137-147.e9. [PMID: 25254613 DOI: 10.1053/j.gastro.2014.09.020] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
22 Ku TH, Zhang T, Luo H, Yen TM, Chen PW, Han Y, Lo YH. Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing. Sensors (Basel) 2015;15:16281-313. [PMID: 26153774 DOI: 10.3390/s150716281] [Cited by in Crossref: 82] [Cited by in F6Publishing: 67] [Article Influence: 11.7] [Reference Citation Analysis]
23 Georgila K, Vyrla D, Drakos E. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer. Cancers (Basel). 2019;11:1097. [PMID: 31374929 DOI: 10.3390/cancers11081097] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]